10-Q Filing

LIFESTANCE HEALTH GROUP, INC. CIK: 1845257 Q2 2022

Filing Information

Form Type	10-Q
Accession Number	`0000950170-22-016508`
Period End Date	20220630
Filing Date	20220810
Fiscal Year	2022
Fiscal Period	Q2
XBRL Instance	lfst-20220630_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 74 Income Statement 76 Cash Flow Statement 77 Stockholders Equity 34

Balance Sheet 74 line items

Line Item	Tag	Value	Unit	Period
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$96.69M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$148.03M	USD	Point-in-time
Preferred Stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred Stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Patient accounts receivable, net	`AccountsReceivableNetCurrent`	$99.74M	USD	Point-in-time
Preferred Stock, Shares Authorized	`PreferredStockSharesAuthorized`	25.00M	shares	Point-in-time
Preferred Stock, Shares Authorized	`PreferredStockSharesAuthorized`	25.00M	shares	Point-in-time
Patient accounts receivable, net	`AccountsReceivableNetCurrent`	$76.08M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$42.41M	USD	Point-in-time
Preferred Stock, Shares Issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred Stock, Shares Issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$47.86M	USD	Point-in-time
Preferred Stock, Shares Outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Total current assets	`AssetsCurrent`	$244.29M	USD	Point-in-time
Preferred Stock, Shares Outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Total current assets	`AssetsCurrent`	$266.52M	USD	Point-in-time
Common Stock, par value	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common Stock, par value	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	800.00M	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$152.24M	USD	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	800.00M	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$190.69M	USD	Point-in-time
Common Stock, Shares, Issued	`CommonStockSharesIssued`	376.18M	shares	Point-in-time
Common Stock, Shares, Issued	`CommonStockSharesIssued`	374.25M	shares	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$282.09M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$300.36M	USD	Point-in-time
Common Stock, Shares, Outstanding	`CommonStockSharesOutstanding`	374.25M	shares	Point-in-time
Goodwill	`Goodwill`	$1.20B	USD	Point-in-time
Goodwill	`Goodwill`	$1.24B	USD	Point-in-time
Common Stock, Shares, Outstanding	`CommonStockSharesOutstanding`	376.18M	shares	Point-in-time
Other noncurrent assets	`OtherAssetsNoncurrent`	$3.45M	USD	Point-in-time
Other noncurrent assets	`OtherAssetsNoncurrent`	$7.89M	USD	Point-in-time
Total noncurrent assets	`AssetsNoncurrent`	$1.66B	USD	Point-in-time
Total noncurrent assets	`AssetsNoncurrent`	$1.72B	USD	Point-in-time
Total assets	`Assets`	$1.97B	USD	Point-in-time
Total assets	`Assets`	$1.93B	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$12.94M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$14.15M	USD	Point-in-time
Accrued payroll expenses	`EmployeeRelatedLiabilitiesCurrent`	$61.22M	USD	Point-in-time
Accrued payroll expenses	`EmployeeRelatedLiabilitiesCurrent`	$60.00M	USD	Point-in-time
Other accrued expenses	`OtherAccruedLiabilitiesCurrent`	$26.21M	USD	Point-in-time
Other accrued expenses	`OtherAccruedLiabilitiesCurrent`	$26.51M	USD	Point-in-time
Current portion of contingent consideration	`BusinessCombinationContingentConsiderationLiabilityCurrent`	$14.12M	USD	Point-in-time
Current portion of contingent consideration	`BusinessCombinationContingentConsiderationLiabilityCurrent`	$8.98M	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$2.19M	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$1.97M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$116.75M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$111.54M	USD	Point-in-time
Long-term debt, net	`LongTermDebtNoncurrent`	$203.36M	USD	Point-in-time
Long-term debt, net	`LongTermDebtNoncurrent`	$157.42M	USD	Point-in-time
Other noncurrent liabilities	`OtherLiabilitiesNoncurrent`	$50.33M	USD	Point-in-time
Other noncurrent liabilities	`OtherLiabilitiesNoncurrent`	$64.54M	USD	Point-in-time
Contingent consideration, net of current portion	`BusinessCombinationContingentConsiderationLiabilityNoncurrent`	$3.65M	USD	Point-in-time
Contingent consideration, net of current portion	`BusinessCombinationContingentConsiderationLiabilityNoncurrent`	$3.31M	USD	Point-in-time
Deferred tax liability, net	`DeferredIncomeTaxLiabilitiesNet`	$54.28M	USD	Point-in-time
Deferred tax liability, net	`DeferredIncomeTaxLiabilitiesNet`	$54.28M	USD	Point-in-time
Total noncurrent liabilities	`LiabilitiesNoncurrent`	$325.84M	USD	Point-in-time
Total noncurrent liabilities	`LiabilitiesNoncurrent`	$265.33M	USD	Point-in-time
Total liabilities	`Liabilities`	$437.38M	USD	Point-in-time
Total liabilities	`Liabilities`	$382.08M	USD	Point-in-time
COMMITMENT AND CONTINGENCIES (see Note 14)	`CommitmentsAndContingencies`	-	USD	Point-in-time
COMMITMENT AND CONTINGENCIES (see Note 14)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock - par value $0.01 per share; 25,000 shares authorized as of June 30, 2022 and December 31, 2021; 0 shares issued and outstanding as of June 30, 2022 and December 31, 2021	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock - par value $0.01 per share; 25,000 shares authorized as of June 30, 2022 and December 31, 2021; 0 shares issued and outstanding as of June 30, 2022 and December 31, 2021	`PreferredStockValue`	-	USD	Point-in-time
Common stock - par value $0.01 per share; 800,000 shares authorized as of June 30, 2022 and December 31, 2021; 376,181 and 374,255 shares issued and outstanding as of June 30, 2022 and December 31, 2021, respectively	`CommonStockValue`	$3.76M	USD	Point-in-time
Common stock - par value $0.01 per share; 800,000 shares authorized as of June 30, 2022 and December 31, 2021; 376,181 and 374,255 shares issued and outstanding as of June 30, 2022 and December 31, 2021, respectively	`CommonStockValue`	$3.74M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$1.90B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$2.02B	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-488.13M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-357.07M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$1.55B	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$1.53B	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$1.97B	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$1.93B	USD	Point-in-time

Income Statement 76 line items

Line Item	Tag	Value	Unit	Period
TOTAL REVENUES	`Revenues`	$412.62M	USD	2 Qtrs
TOTAL REVENUES	`Revenues`	$209.53M	USD	1 Quarter
TOTAL REVENUES	`Revenues`	$160.55M	USD	1 Quarter
TOTAL REVENUES	`Revenues`	$303.68M	USD	2 Qtrs
Center costs, excluding depreciation and amortization shown separately below	`OtherGeneralExpense`	$208.47M	USD	2 Qtrs
Center costs, excluding depreciation and amortization shown separately below	`OtherGeneralExpense`	$298.59M	USD	2 Qtrs
Center costs, excluding depreciation and amortization shown separately below	`OtherGeneralExpense`	$109.34M	USD	1 Quarter
Center costs, excluding depreciation and amortization shown separately below	`OtherGeneralExpense`	$149.70M	USD	1 Quarter
General and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$118.13M	USD	2 Qtrs
General and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$103.56M	USD	1 Quarter
General and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$85.48M	USD	1 Quarter
General and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$206.93M	USD	2 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$32.43M	USD	2 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$16.74M	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$12.77M	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$25.00M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$537.95M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$207.59M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$351.61M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$270.00M	USD	1 Quarter
LOSS FROM OPERATIONS	`OperatingIncomeLoss`	$-47.93M	USD	2 Qtrs
LOSS FROM OPERATIONS	`OperatingIncomeLoss`	$-60.47M	USD	1 Quarter
LOSS FROM OPERATIONS	`OperatingIncomeLoss`	$-47.05M	USD	1 Quarter
LOSS FROM OPERATIONS	`OperatingIncomeLoss`	$-125.32M	USD	2 Qtrs
Loss on remeasurement of contingent consideration	`BusinessCombinationRemeasurementGainLossOnContingentConsideration`	$-614.00K	USD	2 Qtrs
Loss on remeasurement of contingent consideration	`BusinessCombinationRemeasurementGainLossOnContingentConsideration`	$-557.00K	USD	2 Qtrs
Loss on remeasurement of contingent consideration	`BusinessCombinationRemeasurementGainLossOnContingentConsideration`	$-250.00K	USD	1 Quarter
Loss on remeasurement of contingent consideration	`BusinessCombinationRemeasurementGainLossOnContingentConsideration`	$-180.00K	USD	1 Quarter
Transaction costs	`TransactionCosts`	$297.00K	USD	2 Qtrs
Transaction costs	`TransactionCosts`	$2.00M	USD	1 Quarter
Transaction costs	`TransactionCosts`	$19.00K	USD	1 Quarter
Transaction costs	`TransactionCosts`	$3.53M	USD	2 Qtrs
Interest expense	`InterestExpense`	$23.17M	USD	1 Quarter
Interest expense	`InterestExpense`	$31.81M	USD	2 Qtrs
Interest expense	`InterestExpense`	$7.13M	USD	1 Quarter
Interest expense	`InterestExpense`	$10.57M	USD	2 Qtrs
Other expense	`OtherExpenses`	$1.45M	USD	2 Qtrs
Other expense	`OtherExpenses`	-	USD	1 Quarter
Other expense	`OtherExpenses`	$1.36M	USD	1 Quarter
Other expense	`OtherExpenses`	-	USD	2 Qtrs
Total other expense	`NonoperatingIncomeExpense`	$-7.33M	USD	1 Quarter
Total other expense	`NonoperatingIncomeExpense`	$-37.34M	USD	2 Qtrs
Total other expense	`NonoperatingIncomeExpense`	$-26.78M	USD	1 Quarter
Total other expense	`NonoperatingIncomeExpense`	$-11.48M	USD	2 Qtrs
LOSS BEFORE INCOME TAXES	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-85.26M	USD	2 Qtrs
LOSS BEFORE INCOME TAXES	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-136.81M	USD	2 Qtrs
LOSS BEFORE INCOME TAXES	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-73.82M	USD	1 Quarter
LOSS BEFORE INCOME TAXES	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-67.80M	USD	1 Quarter
INCOME TAX (PROVISION) BENEFIT	`IncomeTaxExpenseBenefit`	$923.00K	USD	1 Quarter
INCOME TAX (PROVISION) BENEFIT	`IncomeTaxExpenseBenefit`	$-3.79M	USD	1 Quarter
INCOME TAX (PROVISION) BENEFIT	`IncomeTaxExpenseBenefit`	$-5.75M	USD	2 Qtrs
INCOME TAX (PROVISION) BENEFIT	`IncomeTaxExpenseBenefit`	$-6.55M	USD	2 Qtrs
NET LOSS	`ComprehensiveIncomeNetOfTax`	$-68.73M	USD	1 Quarter
NET LOSS	`ComprehensiveIncomeNetOfTax`	$-131.06M	USD	2 Qtrs
NET LOSS	`ComprehensiveIncomeNetOfTax`	$-70.03M	USD	1 Quarter
NET LOSS	`ComprehensiveIncomeNetOfTax`	$-78.72M	USD	2 Qtrs
Accretion of redeemable class A units	`PreferredStockAccretionOfRedemptionDiscount`	-	USD	1 Quarter
Accretion of redeemable class A units	`PreferredStockAccretionOfRedemptionDiscount`	$36.75M	USD	2 Qtrs
Accretion of redeemable class A units	`PreferredStockAccretionOfRedemptionDiscount`	-	USD	2 Qtrs
Accretion of redeemable class A units	`PreferredStockAccretionOfRedemptionDiscount`	-	USD	1 Quarter
NET LOSS AVAILABLE TO COMMON STOCKHOLDERS/MEMBERS	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-68.73M	USD	1 Quarter
NET LOSS AVAILABLE TO COMMON STOCKHOLDERS/MEMBERS	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-70.03M	USD	1 Quarter
NET LOSS AVAILABLE TO COMMON STOCKHOLDERS/MEMBERS	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-115.47M	USD	2 Qtrs
NET LOSS AVAILABLE TO COMMON STOCKHOLDERS/MEMBERS	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-131.06M	USD	2 Qtrs
Net loss per share, basic	`IncomeLossFromContinuingOperationsPerBasicShare`	$-0.37	USD	2 Qtrs
Net loss per share, basic	`IncomeLossFromContinuingOperationsPerBasicShare`	$-0.19	USD	1 Quarter
Net loss per share, basic	`IncomeLossFromContinuingOperationsPerBasicShare`	$-0.37	USD	2 Qtrs
Net loss per share, basic	`IncomeLossFromContinuingOperationsPerBasicShare`	$-0.22	USD	1 Quarter
Net loss per share, diluted	`IncomeLossFromContinuingOperationsPerDilutedShare`	$-0.37	USD	2 Qtrs
Net loss per share, diluted	`IncomeLossFromContinuingOperationsPerDilutedShare`	$-0.37	USD	2 Qtrs
Net loss per share, diluted	`IncomeLossFromContinuingOperationsPerDilutedShare`	$-0.19	USD	1 Quarter
Net loss per share, diluted	`IncomeLossFromContinuingOperationsPerDilutedShare`	$-0.22	USD	1 Quarter
Weighted-average shares used to compute basic and diluted net loss per share	`WeightedAverageNumberOfSharesOutstandingBasic`	352,297.00	shares	2 Qtrs
Weighted-average shares used to compute basic and diluted net loss per share	`WeightedAverageNumberOfSharesOutstandingBasic`	353,729.00	shares	1 Quarter
Weighted-average shares used to compute basic and diluted net loss per share	`WeightedAverageNumberOfSharesOutstandingBasic`	309,559.00	shares	2 Qtrs
Weighted-average shares used to compute basic and diluted net loss per share	`WeightedAverageNumberOfSharesOutstandingBasic`	313,536.00	shares	1 Quarter

Cash Flow Statement 77 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-131.06M	USD	2 Qtrs
Net loss	`ProfitLoss`	$-78.72M	USD	2 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$32.43M	USD	2 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$16.74M	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$12.77M	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$25.00M	USD	2 Qtrs
Stock and unit-based compensation	`ShareBasedCompensation`	$117.36M	USD	2 Qtrs
Stock and unit-based compensation	`ShareBasedCompensation`	$30.12M	USD	2 Qtrs
Loss on debt extinguishment	`GainsLossesOnExtinguishmentOfDebt`	$-5.62M	USD	2 Qtrs
Loss on debt extinguishment	`GainsLossesOnExtinguishmentOfDebt`	$-3.38M	USD	2 Qtrs
Amortization of discount and debt issue costs	`AmortizationOfFinancingCosts`	$748.00K	USD	2 Qtrs
Amortization of discount and debt issue costs	`AmortizationOfFinancingCosts`	$1.08M	USD	2 Qtrs
Loss on remeasurement of contingent consideration	`LossGainOnRemeasurementOfContingentConsideration`	$-557.00K	USD	2 Qtrs
Loss on remeasurement of contingent consideration	`LossGainOnRemeasurementOfContingentConsideration`	$-614.00K	USD	2 Qtrs
Endowment of shares to LifeStance Health Foundation	`EndowmentOfShares`	-	USD	2 Qtrs
Endowment of shares to LifeStance Health Foundation	`EndowmentOfShares`	$9.00M	USD	2 Qtrs
Patient accounts receivable, net	`IncreaseDecreaseInAccountsReceivable`	$21.90M	USD	2 Qtrs
Patient accounts receivable, net	`IncreaseDecreaseInAccountsReceivable`	$11.83M	USD	2 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$14.96M	USD	2 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$5.35M	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$1.73M	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$2.26M	USD	2 Qtrs
Accrued payroll expenses	`IncreaseDecreaseInWorkersCompensationLiabilities`	$9.58M	USD	2 Qtrs
Accrued payroll expenses	`IncreaseDecreaseInWorkersCompensationLiabilities`	$-289.00K	USD	2 Qtrs
Other accrued expenses	`IncreaseDecreaseInOtherAccruedLiabilities`	$15.28M	USD	2 Qtrs
Other accrued expenses	`IncreaseDecreaseInOtherAccruedLiabilities`	$13.47M	USD	2 Qtrs
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-7.01M	USD	2 Qtrs
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$11.14M	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$31.80M	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$53.77M	USD	2 Qtrs
Acquisitions of businesses, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$39.13M	USD	2 Qtrs
Acquisitions of businesses, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$35.12M	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-70.93M	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-88.89M	USD	2 Qtrs
Proceeds from initial public offering, net of underwriters discounts and commissions and deferred offering costs	`ProceedsFromIssuanceInitialPublicOffering`	-	USD	2 Qtrs
Proceeds from initial public offering, net of underwriters discounts and commissions and deferred offering costs	`ProceedsFromIssuanceInitialPublicOffering`	$554.17M	USD	2 Qtrs
Issuance of common units to new investors	`ProceedsFromContributionsFromAffiliates`	$1.00M	USD	2 Qtrs
Issuance of common units to new investors	`ProceedsFromContributionsFromAffiliates`	-	USD	2 Qtrs
Proceeds from long-term debt, net of discount	`ProceedsFromIssuanceOfLongTermDebt`	$228.00M	USD	2 Qtrs
Proceeds from long-term debt, net of discount	`ProceedsFromIssuanceOfLongTermDebt`	$98.80M	USD	2 Qtrs
Payments of debt issue costs	`PaymentsOfDebtIssuanceCosts`	$2.36M	USD	2 Qtrs
Payments of debt issue costs	`PaymentsOfDebtIssuanceCosts`	$7.18M	USD	2 Qtrs
Payments of long-term debt	`RepaymentsOfLongTermDebt`	$310.73M	USD	2 Qtrs
Payments of long-term debt	`RepaymentsOfLongTermDebt`	$181.23M	USD	2 Qtrs
Prepayment for debt paydown	`PaymentsOfDebtExtinguishmentCosts`	$1.61M	USD	2 Qtrs
Prepayment for debt paydown	`PaymentsOfDebtExtinguishmentCosts`	-	USD	2 Qtrs
Payments of contingent consideration	`PaymentForContingentConsiderationLiabilityFinancingActivities`	$11.09M	USD	2 Qtrs
Payments of contingent consideration	`PaymentForContingentConsiderationLiabilityFinancingActivities`	$5.59M	USD	2 Qtrs
Taxes related to net share settlement of equity awards	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	-	USD	2 Qtrs
Taxes related to net share settlement of equity awards	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$478.00K	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$335.29M	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$26.41M	USD	2 Qtrs
NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$257.36M	USD	2 Qtrs
NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-51.34M	USD	2 Qtrs
Cash and Cash Equivalents - Beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$148.03M	USD	Point-in-time
Cash and Cash Equivalents - Beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$276.19M	USD	Point-in-time
Cash and Cash Equivalents - Beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$18.83M	USD	Point-in-time
Cash and Cash Equivalents - Beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$96.69M	USD	Point-in-time
CASH AND CASH EQUIVALENTS END OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$148.03M	USD	Point-in-time
CASH AND CASH EQUIVALENTS END OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$276.19M	USD	Point-in-time
CASH AND CASH EQUIVALENTS END OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$18.83M	USD	Point-in-time
CASH AND CASH EQUIVALENTS END OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$96.69M	USD	Point-in-time
Cash paid for interest	`InterestPaidNet`	$4.93M	USD	2 Qtrs
Cash paid for interest	`InterestPaidNet`	$24.89M	USD	2 Qtrs
Cash paid for taxes, net of refunds	`IncomeTaxesPaidNet`	$900.00K	USD	2 Qtrs
Cash paid for taxes, net of refunds	`IncomeTaxesPaidNet`	$860.00K	USD	2 Qtrs
Unpaid deferred offering costs included in accounts payable and other accrued expenses	`UnpaidDeferredOfferingCostsIncludedInAccountsPayableAndOtherAccruedExpenses`	-	USD	2 Qtrs
Unpaid deferred offering costs included in accounts payable and other accrued expenses	`UnpaidDeferredOfferingCostsIncludedInAccountsPayableAndOtherAccruedExpenses`	$5.26M	USD	2 Qtrs
Equipment financed through capital leases	`EquipmentFinancedThroughCapitalLeases`	$256.00K	USD	2 Qtrs
Equipment financed through capital leases	`EquipmentFinancedThroughCapitalLeases`	$14.00K	USD	2 Qtrs
Contingent consideration incurred in acquisitions of businesses	`ContingentConsiderationIncurredInAcquisitionsOfBusinesses`	$2.74M	USD	2 Qtrs
Contingent consideration incurred in acquisitions of businesses	`ContingentConsiderationIncurredInAcquisitionsOfBusinesses`	$5.68M	USD	2 Qtrs
Acquisition of property and equipment included in liabilities	`PurchaseOfPropertyPlantAndEquipmentIncludedInAccountsPayableAndAccruedExpenses`	$13.05M	USD	2 Qtrs
Acquisition of property and equipment included in liabilities	`PurchaseOfPropertyPlantAndEquipmentIncludedInAccountsPayableAndAccruedExpenses`	$10.23M	USD	2 Qtrs
Issuance of common units for acquisitions of businesses	`IssuanceOfCommonUnitsForAcquisitionsOfBusinesses`	$1.49M	USD	2 Qtrs
Issuance of common units for acquisitions of businesses	`IssuanceOfCommonUnitsForAcquisitionsOfBusinesses`	$1.49M	USD	1 Quarter
Issuance of common units for acquisitions of businesses	`IssuanceOfCommonUnitsForAcquisitionsOfBusinesses`	-	USD	2 Qtrs

Stockholders Equity 34 line items

Line Item	Tag	Value	Unit	Period
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.54B	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.54B	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.53B	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$997.84M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$954.01M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.55B	USD	Point-in-time
Net loss	`NetIncomeLoss`	$-131.06M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-68.73M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-70.03M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-78.72M	USD	2 Qtrs
Issuance of common stock upon vesting of restricted stock units	`StockIssuedDuringPeriodValueRestrictedStockUnitsReleases`	$-37.00K	USD	2 Qtrs
Forfeitures, value	`StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures`	$-185.00K	USD	2 Qtrs
Issuance of common units	`StockIssuedDuringPeriodValueNewIssues`	$1.00M	USD	2 Qtrs
Accretion of redeemable class A units	`PreferredStockAccretionOfRedemptionDiscount`	-	USD	1 Quarter
Accretion of redeemable class A units	`PreferredStockAccretionOfRedemptionDiscount`	$36.75M	USD	2 Qtrs
Accretion of redeemable class A units	`PreferredStockAccretionOfRedemptionDiscount`	-	USD	2 Qtrs
Accretion of redeemable class A units	`PreferredStockAccretionOfRedemptionDiscount`	-	USD	1 Quarter
Issuance of common units for acquisitions of businesses	`IssuanceOfCommonUnitsForAcquisitionsOfBusinesses`	$1.49M	USD	2 Qtrs
Issuance of common units for acquisitions of businesses	`IssuanceOfCommonUnitsForAcquisitionsOfBusinesses`	$1.49M	USD	1 Quarter
Issuance of common units for acquisitions of businesses	`IssuanceOfCommonUnitsForAcquisitionsOfBusinesses`	-	USD	2 Qtrs
Conversion of Redeemable Class A Units into common stock upon closing of initial public offering, Value	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	$71.75M	USD	2 Qtrs
Conversion of Redeemable Class A Units into common stock upon closing of initial public offering, Value	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	$71.75M	USD	1 Quarter
Endowment of shares to the LifeStance Health Foundation, value	`StockIssuedDuringPeriodValueIssuedForServices`	$9.00M	USD	2 Qtrs
Endowment of shares to the LifeStance Health Foundation, value	`StockIssuedDuringPeriodValueIssuedForServices`	$9.00M	USD	1 Quarter
Stock and unit-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$29.52M	USD	1 Quarter
Stock and unit-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$117.55M	USD	2 Qtrs
Stock and unit-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$30.12M	USD	2 Qtrs
Stock and unit-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$57.51M	USD	1 Quarter
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.54B	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.54B	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.53B	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$997.84M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$954.01M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.55B	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.